A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

ClinicalTrials.gov ID: NCT07491497

Public ClinicalTrials.gov record NCT07491497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 2:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Dose Escalation and Expansion Study of TRI-611, an Oral ALK Molecular Glue Degrader in Participants With Advanced ALK-Positive NSCLC

Study identification

NCT ID: NCT07491497
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: TRIANA Biomedicines, Inc.; Industry
Enrollment: 160 participants

Conditions and interventions

Conditions

Interventions

TRI-611 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 10, 2026
Primary completion: May 30, 2029
Completion: Jan 29, 2034
Last update posted: May 6, 2026

2026 – 2034

United States locations

U.S. sites: 7
U.S. states: 7
U.S. cities: 7

Facility	City	State	ZIP	Site status
University of Colorado Cancer Center	Aurora	Colorado	80045	Recruiting
Washington University Medical Center	St Louis	Missouri	63130	Recruiting
Memorial Sloan-Kettering Cancer Center	New York	New York	10065	Recruiting
Taylor Cancer Research Center	Maumee	Ohio	43537	Recruiting
SCRI Oncology Partners	Nashville	Tennessee	37203	Recruiting
START Mountain Region	West Valley City	Utah	84119	Recruiting
NEXT Virginia	Fairfax	Virginia	22031	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07491497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 6, 2026 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07491497 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →